Granules India announced that the US FDA has completed inspection of the facility of Granules
Pharmaceuticals, Inc., a whollyowned foreign subsidiary of the Company located in
Chantilly, Virginia, USA on 21 August 2019 with two (2) minor observations. This is a pre-approval inspection for seven products filed from this facility. Granules Pharmaceuticals, Inc.
will respond to these observations within the stipulated time period.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
